Oncologic Outcomes of Sequential Intravesical Gemcitabine and Docetaxel Compared with Bacillus Calmette-Guérin in Patients with Bacillus Calmette-Guérin–Unresponsive Non–Muscle Invasive Bladder Cancer
Jacob Taylor, Ashish M. Kamat, Drupad Annapureddy, Z. Khene, Jeffrey T. Howard, Wei Shen Tan, Ian M. McElree, Davaro Facundo, Kendrick Yim, Stephen Harrington, Elizabeth Dyer, Anna J. Black, Pratik Kanabur, M. Roumiguié, Seth Lerner, Peter C. Black, Jay D. Raman, Mark Preston, Gary D. Steinberg, William C. Huang, Roger Li, Vignesh T. Packiam, Solomon L. Woldu, Yair Lotan, Michael A. O’Donnell
Topics & Concepts
MedicineDocetaxelGemcitabineBladder cancerBacillus (shape)UrologyOncologyInternal medicineCancerMicrobiologyBiologyBladder and Urothelial Cancer TreatmentsUrinary and Genital Oncology StudiesImmune responses and vaccinations